Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| DECHENG CAPITAL MANAGEMENT III (CAYMAN) LLC | 11-13-2023 | 09-30-2023 | 27 | 312,948,514 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| Alpine Immune Sciences, Inc. | COM | 1 | $76,809,898 | 6,708,288 | 0.02 | 0.02 | 0 | 0.00 | 09-30-2023 |
| Zentalis Pharmaceuticals Inc. | COM | 2 | $42,117,635 | 2,099,583 | 0.01 | 0.02 | 0 | 0.00 | 09-30-2023 |
| Aura Biosciences, Inc. | COM | 3 | $18,243,928 | 1,163,123 | 0.01 | 0.00 | 869,790 | 296.52 | 09-30-2023 |
| ROIVANT SCIENCES LTD | COM | 4 | $17,049,296 | 1,459,700 | 0.01 | 0.00 | 0 | 0.00 | 09-30-2023 |
